Cellosaurus SpESFX-10 (CVCL_WS50)
Cell line name | SpESFX-10 |
---|---|
Synonyms | SpESF-X10; SpESFX clone 10 |
Accession | CVCL_WS50 |
Resource Identification Initiative | To cite this cell line use: SpESFX-10 (RRID:CVCL_WS50) |
Comments | Group: Hybridoma fusion partner cell line. Group: Patented cell line. Group: Serum/protein free medium cell line. Characteristics: Transfected with a hBCL2-EEE-pZeoSV2+ construct. Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine. Genetic integration: Method=Transfection/transduction; Gene=HGNC; 990; BCL2 (Note=With p.Thr69Glu, p.Ser70Glu and p.Ser87Glu = BCL2-EEE). Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR). |
Disease | Mouse plasma cell myeloma (NCIt: C125417) |
Species of origin | Mus musculus (Mouse) (NCBI Taxonomy: 10090) |
Hierarchy | Parent: CVCL_WS49 (SpESFX) |
Sex of cell | Female |
Category | Cancer cell line |
Publications | Patent=US7608425 PubMed=21473000; DOI=10.1002/btpr.584 |
Cross-references | |
Cell line databases/resources | FCS-free; 137-17-240-3-4-12 |
Encyclopedic resources | Wikidata; Q98132816 |
Entry history | |
Entry creation | 05-Jul-2019 |
Last entry update | 10-Sep-2024 |
Version number | 5 |